Publication | Open Access
Continuous versus intermittent BRAF and MEK inhibition in patients with BRAF-mutated melanoma: a randomized phase 2 trial
108
Citations
19
References
2020
Year
Tumor BiologyRandomized Phase 2MedicineMelanomaImmunologyImmune Checkpoint InhibitorBraf-mutated MelanomaMek InhibitionCancer TreatmentOncologyRadiation OncologyMolecular Oncology
| Year | Citations | |
|---|---|---|
Page 1
Page 1